The Harvard Crimson, September 24, 2013
Andrew Ma


Read the Full Article

"Panelists at Monday’s discussion about the recent Supreme Court decision against gene patenting agreed that although patenting might provide incentives to aspiring innovators, it often hinders scientific progress, especially when it concerns the DNA sequences that are found within human bodies.

"Students and professionals alike gathered in Austin Hall at the Harvard Law School to listen to a panel of six participants, each with different backgrounds and perspectives on the recent case in which the Court ruled that Myriad Genetics, a biotechnology firm in Utah, could not legally patent genes found in human DNA.

"The panelists addressed the question posted by moderator and Harvard Law School Dean Martha L. Minow: 'What exactly is patentable?”'" [...]

biotechnology genetics i. glenn cohen judicial opinions